Sharing a good local news story for patients - early days for the adoption of gene therapies for IRD and to emphasis how new/cutting edge PYC ocular therapies are.
I get the feeling helping patients is what motivates Sue and the PYC team - and are striving hard towards.
The complexity/delivery of current tech is worth noting, PYC will surprise ease of an intravenous injection within a GP type consulting room vs full fledged operating theatre will surprise the industry I think
https://www.insightnews.com.au/sydney-surgeon-details-first-luxturna-gene-therapy-allowing-patient-to-see-stars/#mobile-site-navigation
Sharing a good local news story for patients - early days for...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 592 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 4211 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |